• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10622
Device Problem Failure to Advance (2524)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/26/2022
Event Type  malfunction  
Manufacturer Narrative
Initial reporter address 1: (b)(6).Device evaluated by mfr.: synergy ous mr 3.00 x 32mm stent delivery system was returned for analysis.A visual examination of the stent found distal stent damage with strut lifted.The undamaged stent outer diameter was measured using snap gauge within max crimped stent profile measurement.The balloon cones were reviewed, and no issues were noted.The balloon wings were tightly wrapped and evenly folded and were not subjected to positive pressure.A visual and microscopic examination of the bumper tip showed no signs of distal tip damage.A visual and tactile examination of the hypotube shaft found a shaft break at approx.119.5cm distal to the distal end of the strain relief.A visual and tactile examination of the outer and mid-shaft section and a visual examination of the inner lumen found no issues along the shaft polymer extrusion.
 
Event Description
Reportable based on device analysis completed on (b)(6) 2022.It was reported that crossing difficulties were encountered.The patient presented with coronary artery disease and underwent percutaneous transluminal coronary angioplasty.The 70% stenosed target lesion was located in the severely tortuous and severely calcified left anterior descending artery.After a 6f guide catheter was engaged, pre-dilation was performed with a 2.00 x 12 mm balloon.A 3.00 x 32 synergy drug-eluting stent was advanced but failed to cross the lesion.The device was removed intact, and the procedure was completed with a non-boston scientific device.There were no patient complications reported and the patient status was stable.However, returned device analysis revealed a shaft break.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
4100 hamline ave n
arden hills, MN 55112
6515810888
MDR Report Key16054010
MDR Text Key308266628
Report Number2124215-2022-54246
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial
Report Date 12/27/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/27/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date01/12/2024
Device Model Number10622
Device Catalogue Number10622
Device Lot Number0028747685
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer11/29/2022
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/20/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured01/12/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
GUIDE CATHETER - 6F.
Patient SexFemale
Patient RaceAsian
-
-